Fundraising Fox

Route 92 Medical

San Mateo, US · Delaware corporation · 5 known investors

r92m.com ↗

Route 92 Medical develops medical devices and procedural approaches for neurovascular intervention, targeting challenges in neurointervention such as acute ischemic stroke. Founded by physicians in collaboration with clinicians, the company designs products aimed at improving procedural and patient outcomes.

BiotechHardwareHealthtechMedical Devices

Founders & leadership

DC
Dr. ChouFounder & Chief Executive Officer
CLCindy Lynch
Cindy LynchExecutive
TCTony Chou
Tony ChouNamed on SEC filingGeneral Partner at The Vertical Group

Board

JLJack Lasersohn
Jack LasersohnBoard directorGeneral Partner at The Vertical Group
TM
Tamir MeiriBoard director
JRJonathan Root
Jonathan RootinBoard directorGeneral Partner at US Venture Partners
AG
Ariella GolombBoard director
NJNoel Jee
Noel Jeein𝕏Board directorPrincipal at Sofinnova Ventures
CDCasper de Clercq
Casper de Clercqin𝕏Board directorGeneral Partner at Norwest Venture Partners
JEJohn E. Runnells
John E. RunnellsBoard directorGeneral Partner at The Vertical Group

Investors · 5

Norwest Venture PartnersMenlo Park · $10M – $30Mvia Casper de Clercq · board
Runway Growth CapitalMenlo Park · $10M – $150M
US Venture PartnersMenlo Park · $500K – $10M
Sofinnova VenturesreportedMenlo Park · $100K – $15Mvia Noel Jee · board
The Vertical GroupreportedBerkeley Heights · $250K – $5Mvia Jack W. Lasersohn · board

Reported raises · per SEC filings

Form D private placements

$208.1M disclosed across 8 rounds · 2016–2026

▶$50MraisedApr 2026 · 11 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Tony M. ChouExecutive Officer, Director
  • Ariella GolombDirector
  • John MillerExecutive Officer
  • Noel JeeDirector
  • Jonathan RootDirector
  • Jack W. LasersohnDirector
  • J. Patrick MackinDirector
  • Mitchell HillDirector
  • Cindy LynchExecutive Officer
  • Lucas BuchananDirector
  • Randall SullivanExecutive Officer
  • Kirsten ValleyExecutive Officer
  • Chris HartmanExecutive Officer
  • Casper de ClercqDirector
Offering amount
$50M
Amount sold
$50M
First sale
Jan 2026
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$50.4MraisedJul 2024 · 5 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Tony ChouExecutive Officer, Director
  • Jack LasersohnDirector
  • Tamir MeiriDirector
  • Jonathan RootDirector
  • Cindy LynchExecutive Officer
  • Ariella GolombDirector
  • Noel JeeDirector
  • Casper de ClercqDirector
Offering amount
$50.4M
Amount sold
$50.4M
First sale
Jun 2024
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$31.3MraisedNov 2023 · 4 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Jack LasersohnDirector
  • Cindy LynchExecutive Officer
  • Jonathan RootDirector
  • Tony ChouExecutive Officer, Director
  • Casper de ClercqDirector
  • Ariella GolombDirector
Offering amount
$31.3M
Amount sold
$31.3M
First sale
Nov 2023
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$46.9MraisedJul 2021 · 4 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Tony ChouExecutive Officer, Director
  • Ariella GolombDirector
  • Jonathan RootDirector
  • Jack LasersohnDirector
  • Casper de ClercqDirector
  • Cindy LynchExecutive Officer
Offering amount
$61M
Amount sold
$46.9M
First sale
Jun 2021
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$13MraisedMay 2019 · 2 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Tony ChouExecutive Officer, Director
  • Jonathan RootDirector
  • Casper de ClercqDirector
  • John E. RunnellsExecutive Officer
  • Jack LasersohnDirector
Offering amount
$13M
Amount sold
$13M
First sale
May 2019
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$4.7MraisedAug 2018 · 1 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • John E. RunnellsExecutive Officer
  • Jack LasersohnDirector
  • Tony ChouExecutive Officer, Director
  • Jonathan RootDirector
Offering amount
$6.7M
Amount sold
$4.7M
First sale
Aug 2018
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$5.9MraisedMay 2017 · 1 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Tony ChouExecutive Officer, Director
Offering amount
$5.9M
Amount sold
$5.9M
First sale
Apr 2017
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$5.9MraisedMay 2016 · 1 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Tony ChouExecutive Officer, Director
  • John E. RunnellsExecutive Officer
  • Jonathan RootDirector
  • Jack LasersohnExecutive Officer, Director
Offering amount
$5.9M
Amount sold
$5.9M
First sale
May 2016
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Frequently asked questions

What does Route 92 Medical do?
Route 92 Medical develops medical devices and procedural approaches for neurovascular intervention, targeting challenges in neurointervention such as acute ischemic stroke. Founded by physicians in collaboration with clinicians, the company designs products aimed at improving procedural and patient outcomes.
Who founded Route 92 Medical?
Route 92 Medical was founded by Dr. Chou.
Who are Route 92 Medical's investors?
Route 92 Medical's investors include Norwest Venture Partners, Runway Growth Capital, US Venture Partners, Sofinnova Ventures, The Vertical Group.
How much funding has Route 92 Medical raised?
Route 92 Medical has disclosed $208.1M raised across 8 rounds.
Where is Route 92 Medical headquartered?
Route 92 Medical is headquartered in San Mateo, US.